Cencora Inc. (COR) scored on five pillars from its reported financial statements, and ranked against 212 Healthcare companies.
Cencora Inc. (COR) scores 6.7 out of 10 as of , computed from its reported financial statements. That reads as solid quality. The reading rests on efficiency, and growth is what holds it back.
Data provided by Twelve Data. Scores are computed by Lemma Analysis from reported financials.
We cannot judge Cencora Inc. yet, because fewer than five years had both a return on capital and a cost of capital we could measure. This is not a “no”.
Quantitative signs of a moat, read from the filed statements. This is not a judgement of where it comes from (brand, network effects, switching costs). How Lemma measures a moat →
Cencora Inc. (COR) has a Lemma Quality Score of 6.7 out of 10 as of October 19, 2026, which reads as solid quality. A solid reading is a respectable business with clear strengths and at least one area that falls short of the best in its field. Five pillars feed it, and every one of them is computed from what the company reported rather than from its share price.
Among the 212 Healthcare companies with a published score, that ranks at the 86th percentile, inside the top quarter of the group. The median across the group is 4.4, and the top quarter begins at 6.0, so Cencora Inc. is well above the typical company here.
Profitability scores 6.0 out of 10, which reads as average. The median across 210 Healthcare companies is 2.7, so Cencora Inc. is well above its peers on this pillar and ranks at the 79th percentile. Middling returns are common and not a flaw in themselves, though they leave less slack when costs rise or demand softens.
Cencora Inc.’s solvency score is 5.5 out of 10 (average). Against a median of 6.5 among 150 Healthcare companies, that is below the group and the 35th percentile. Middling solvency says the balance sheet is neither a strength nor a constraint today.
Cencora Inc.’s growth score is 5.0 out of 10 (average). Against a median of 4.9 among 107 Healthcare companies, that is in line with the group and the 52nd percentile. Growth near the median is neither a reason to buy nor a concern, but it does mean the quality case rests more on the other pillars.
Cencora Inc.’s efficiency score is 9.0 out of 10 (strong). Against a median of 6.0 among 200 Healthcare companies, that is well above the group and the 93rd percentile. A strong efficiency reading usually shows up as healthy cash conversion: reported profit arriving as real cash rather than staying on the balance sheet.
Cencora Inc.’s predictability score is 8.7 out of 10 (strong). Against a median of 3.4 among 207 Healthcare companies, that is well above the group and the 99th percentile. A strong predictability score rewards consistency: revenue and earnings that rarely surprise in either direction.
This is a lopsided profile. Efficiency scores 9.0 but growth only 5.0, a gap of 4.0 points, so the overall hides a business that is excellent in one respect and weak in another. An efficiency lead means the operation turns what it has into cash better than it does anything else. A growth shortfall often comes with size or a maturing market, and is less of a concern if the other pillars are strong.
Closing the gap on solvency would do the most for the overall. At the median of Healthcare companies, 6.5, Cencora Inc. would score about 6.9 instead of 6.7. All five pillars could be scored, so the overall uses the full set of weights out of 100: profitability 25, solvency 20, growth 20, efficiency 15, predictability 20.
These are the Healthcare companies closest to Cencora Inc. in market value. Each has its own page scored on the same five pillars, so the comparison is like for like.
How much profit the company generates from its capital and sales.
The company’s ability to service debt and meet its obligations.
How fast revenue, earnings and cash flow are compounding.
How well assets and earnings convert into cash and output.
How stable and consistent results have been over time.
Each metric is scored from 0 to 10 against sector-aware benchmarks, where higher is better. Metrics roll up into five pillars, and the pillars combine into the overall score using the weights shown. Sector-sensitive metrics are judged relative to peers in the same sector.
This score is a systematic, backward-looking read of reported fundamentals. It does not judge valuation, management quality, competitive moat, or future prospects, and can be distorted by one-off items or unusual accounting. Treat it as a starting point, not a recommendation.
Educational only. Not investment advice.
On this reading Cencora Inc. scores 6.7 out of 10, which reads as solid quality. Its strongest pillar is efficiency, its weakest is growth. Quality is not the same as a good investment: the score says nothing about the price you would pay.
Cencora Inc. ranks at the 86th percentile of the 212 Healthcare companies Lemma publishes a score for. The median there is 4.4 and the top quarter starts at 6.0, against Cencora Inc.’s 6.7.
Five pillars, each scored from 0 to 10 against sector-aware benchmarks and then weighted into one overall reading: profitability, solvency, growth, efficiency and predictability. Everything comes from reported financials, and nothing comes from price, sentiment or forecasts.
This page last changed on October 19, 2026. The score moves with the financial statements, so the page changes when a new filing moves the reading rather than on a schedule. Live figures for COR are in the app.
No. Quality and valuation are separate questions, and a good business at the wrong price is still a bad purchase. Score the business here, then price it with a DCF you control.
Inside Lemma Analysis the same five pillars run on every company we cover, with the metrics behind each one, current fundamentals, a DCF you control and a watchlist that tells you when the price catches up.
Free to start · No credit card